Las Vegas, NV -- (SBWIRE) -- 10/05/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is On: Cubist Pharmaceuticals Inc (NASDAQ:CBST), Lexicon Pharmaceuticals, Inc.(NASDAQ:LXRX), Sangamo Biosciences, Inc.(NASDAQ:SGMO), Universal American Corporation (NYSE:UAM)
Cubist Pharmaceuticals Inc (NASDAQ:CBST) managed to keep its gain at 0.48% on below-normal volume of 1.05M shares. The stock settled at $63.18 after floating in a range of $62.86 to $63.38. Its latest price has reached market capitalization of $4.18B. Its 52-week range has been $38.53 to $68.00. Cubist Pharmaceuticals, Inc. (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of therapies to treat serious medical conditions in acutely ill patients who are hospitalized or are being treated in other acute care settings.
Is CBST Ready To Move Up? Find Out Here
Lexicon Pharmaceuticals, Inc.(NASDAQ:LXRX) traded on a volume of 1.03M Shares, lower than its standard daily volume. Shares have closed at $2.88. Over the last twelve months, the stock has gained 30.32% and faced a worst price of $1.55. Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
Is LXRX a Solid Investment at These Levels? Read This Report for Details
Sangamo Biosciences, Inc.(NASDAQ:SGMO) settled down at $12.65 on above-normal volume of 1.03M shares during the last trading day. The stock has its 12-month high at $13.20 and 52-week low price was $4.92. It traded in a range of $12.60 to $13.20 during the last trading day. Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company.
Is SGMO a Solid Investment at These Levels? Just Go Here and Find Out
In the last trading session, Universal American Corporation (NYSE:UAM) was on high volume, trading at a volume of 1.01M versus its average daily volume of 194,729 shares. At $7.80, the stock has attained market capitalization of 692.91M. Universal American Corp., through its health insurance and managed care subsidiaries, primarily serves the growing Medicare population by providing Medicare Advantage products.
Will Investors Buy UAM After Reading This News? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)